All Stories

  1. Symptoms, signs, suspicion and setting: a PESI score for cancer-associated pulmonary embolism?
  2. Effect of combined treatment with immunoadsorption and membrane filtration on plasma coagulation-Results of a randomized controlled crossover study
  3. Hemoglobin, alkalic phosphatase, and C-reactive protein predict the outcome in patients with liposarcoma
  4. Estimating risk of venous thromboembolism in patients with cancer in the presence of competing mortality
  5. Microparticle-associated tissue factor activity in patients with acute unprovoked deep vein thrombosis and during the course of one year
  6. Statins are Associated with Low Risk of Venous Thromboembolism in Patients with Cancer: A Prospective and Observational Cohort Study
  7. Red Cell Distribution Width and Other Red Blood Cell Parameters in Patients with Cancer: Association with Risk of Venous Thromboembolism and Mortality
  8. Chronic kidney disease in patients with cancer and its association with occurrence of venous thromboembolism and mortality
  9. Characterisation of inflammatory response, coagulation, and radiological findings in Katayama fever: a report of three cases at the Medical University of Vienna, Austria
  10. Risk factors for venous thromboembolism in cancer: novel findings from the Vienna Cancer and Thrombosis Study (CATS)
  11. Comparison of metal on metal versus polyethylene–ceramic bearing in uncemented total hip arthroplasty in patients with haemophilic arthropathy
  12. Outcome of Total Knee Arthroplasty in Hemophilic Arthropathy
  13. Clinical evidence for a link between microparticle-associated tissue factor activity and overt disseminated intravascular coagulation in patients with acute myelocytic leukemia
  14. Microparticle-associated tissue factor activity in patients with metastatic pancreatic cancer and its effect on fibrin clot formation
  15. Residual thrombin generation potential is inversely linked to the occurrence of atherothrombotic events in patients with peripheral arterial disease
  16. Association of Thrombin Generation Potential with Platelet PAR-1 Regulation and P-Selectin Expression in Patients on Dual Antiplatelet Therapy
  17. Response to antiplatelet therapy is independent of endogenous thrombin generation potential
  18. Microparticle-associated tissue factor activity in patients with pancreatic cancer: correlation with clinicopathological features
  19. Intratumoral tissue factor expression and risk of venous thromboembolism in brain tumor patients
  20. Surgical treatment of the haemophilic pseudotumour: A single centre experience
  21. Association of elevated soluble P-selectin levels with fetal loss in women with a history of venous thromboembolism
  22. Predictive potential of haemostatic biomarkers for venous thromboembolism in cancer patients
  23. Soluble p-selectin, D-dimer, and high-sensitivity C-reactive protein after acute deep vein thrombosis of the lower limb
  24. Thrombin generation in type 2 diabetes with albuminuria and macrovascular disease
  25. The P-selectin gene Pro715 allele and low levels of soluble P-selectin are associated with reduced P2Y12 adenosine diphosphate receptor reactivity in clopidogrel-treated patients
  26. Platelet activation and function during eltrombopag treatment in immune thrombocytopenia
  27. Thrombin generation in patients with a bleeding tendency of unknown origin
  28. Long-term survival of patients with a history of venous thromboembolism
  29. Circulating procoagulant microparticles in cancer patients
  30. Combined effects of genetic polymorphisms of P-selectin and P-selectin glycoprotein ligand-1 on the binding of platelets to monocytes
  31. Tests predictive of thrombosis in cancer
  32. Function of platelets in apheresis platelet concentrates and in patient blood after transfusion as assessed by Impact-R
  33. Immunthrombozytopenie
  34. Circulating procoagulant microparticles in patients with venous thromboembolism
  35. P-selectin gene haplotypes modulate soluble P-selectin concentrations and contribute to the risk of venous thromboembolism
  36. Successful outcome in a pregnant woman with homozygous antithrombin deficiency
  37. The angiotensin-converting enzyme insertion/deletion polymorphism and serum levels of angiotensin-converting enzyme in venous thromboembolism. Data from a case control study